PT0141

PT0141 (Bremelanotide) is a synthetic cyclic peptide analog supplied as a high-purity lyophilized compound intended exclusively for laboratory research use by qualified professionals. Manufactured under controlled conditions to ensure batch consistency, analytical reliability, and stability.
For laboratory research use only. 

Available concentrations: 10 mg

Technical Classification

• Peptide Type: Synthetic cyclic peptide

• Peptide Class: Melanocortin receptor agonist analog

• Structural Type: Cyclic heptapeptide derivative

• Source: Synthetic (laboratory-produced)

• Physical Form: Lyophilized powder

• Purity: >99% (HPLC)

Research Context

PT0141 is utilized in preclinical and experimental research settings investigating:

• Melanocortin receptor signaling pathways (MC3R, MC4R)

• Central nervous system peptide signaling

• Neuroendocrine regulation and neurotransmitter modulation

• Sexual behavior and arousal signaling pathways in experimental models

• Hypothalamic and limbic system interactions

• Peptide-receptor binding dynamics and downstream signaling cascades

Research involving PT-141 focuses on mechanistic exploration of melanocortin-mediated pathways, receptor activation profiles, and central signaling effects in in vitro and animal models. Research applications are limited to biological pathway analysis and experimental modeling, not therapeutic use.

Handling & Storage

• Storage Conditions: 2–8 °C, protected from light

• Stability: Lyophilized format supports extended stability when stored under recommended conditions

• Reconstitution: For laboratory research protocols only, using appropriate sterile laboratory techniques